Metraipolis › archive › dc_53eddf4a4ce2
An integrated approach based on FDA adverse event reporting system, network pharmacology, molecular docking, and molecular dynamics simulation analysis to… — Europe PMC PMID:40552149
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40552149
- DOI
- 10.3389/fphar.2025.1619517
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T15:15:45.768Z
- SHA-256 of the archived text
62bdfbcb6429acecb44ab94645922270e13b1f3f9c125c9a038ecefa4385a8fc- Stable URL of this page
https://metraipolis.com/documento/dc_53eddf4a4ce2
How to cite
An integrated approach based on FDA adverse event reporting system, network pharmacology, molecular docking, and molecular dynamics simulation analysis to… — Europe PMC PMID:40552149 — Europe PMC (en), https://europepmc.org/article/MED/40552149 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_53eddf4a4ce2 (Metraipolis archive dc_53eddf4a4ce2, sha256 62bdfbcb6429acecb44ab94645922270e13b1f3f9c125c9a038ecefa4385a8fc)
BibTeX
@misc{dc53eddf4a4ce2,
title = {An integrated approach based on FDA adverse event reporting system, network pharmacology, molecular docking, and molecular dynamics simulation analysis to… — Europe PMC PMID:40552149},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40552149},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_53eddf4a4ce2; sha256 62bdfbcb6429acecb44ab94645922270e13b1f3f9c125c9a038ecefa4385a8fc},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40552149. Agents can read the archived copy with the MCP tool read_document.